Trial document



drksid header

  DRKS00006865

Trial Description

start of 1:1-Block title

Title

Randomized clinical trial to prove the effectiveness of a spine orthosis (Spinova Support Plus by Bauerfeind) for the postoperative treatment after lumbar spinal fusion of one or two segments in L3-S1 due to degenerative lumbar spine desease

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

AWB/Spinova-01

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Before doing a fusion of the lower lumbar spine, patients are classified into two groups by chance. One group receives a spine orthosis (Spinova Support Plus by Bauerfeind) after surgery for supporting the rehabilition, the other one doesn't. During rehabilitation the clinical outcome is measured by questionaires and the endurance of the back muscles is measured by a surface elektromyogramm.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

This is a randoized clinical trial for the postoperative treatment after lumbar spinal fusion of one or two segments in L3-S1 due to degenerative lumbar spine desease. One group receives a spine orthosis (Spinova Support Plus by Bauerfeind), the other one doesn't. In both groups the clinical outcome is measured by questionaires (Oswestry Disability Index, VAS, patient satisfaction). In addition an surface electromyogramm is done for diagnosing the fatigue index of the erector spinae.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00006865
  •   2014/10/13
  •   [---]*
  •   no
  •   Approved
  •   381/13, Ethik-Kommission der Medizinischen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   M53.26 -  [generalization M53.2: Spinal instabilities]
  •   M42.16 -  [generalization M42.1: Adult osteochondrosis of spine]
  •   M43.16 -  [generalization M43.1: Spondylolisthesis]
  •   M47.86 -  [generalization M47.8: Other spondylosis]
  •   M48.06 -  [generalization M48.0: Spinal stenosis]
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Additional to the standard postoperative treatment, patients receive a spinal orthosis (Spinova Support Plus by Bauerfeind) for 12 weeks after surgery. After 6 weeks the bridging pad of the orthesis is removed.
  •   The patients receive standard postoperative treatment after surgery without orthosis.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Randomized controlled trial
  •   Open (masking not used)
  •   [---]*
  •   Active control
  •   Supportive care
  •   Parallel
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Primary aim is to prove the additional benefit of a spine othosis after lumbar fusion.
To demonstrate the difference in the postoperative treatment, all patients of both groups receive questionaires about their aktivities of daily living (Oswestry Disability Index), about pain (visual analogue scale) and about the satisfaction (very satisfied, satisfied, largely satisfied, partially satisfied, rarely satisfied, not satisfied) before surgery and at the time of discharge. Patients receive further questionaires 6 weeks, 12 weeks, 6 months and 12 months after surgery.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Secondary aim is to show a better endurance of the erector spinae in the group of patients, who receive a spinal orthosis.
To prove that assumption, the muscle fatigue index is derived fom a surface EMG of the erector spinae at all patients of both groups before surgery and at the time of discharge, 6 weeks and 12 weeks after surgery.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Planned
  •   2014/10/10
  •   50
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   25   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

Patients after lumbar spinal fusion of one or two segments in L3-S1 due to degenerative lumbar spine desease

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

Age <25; Patients, who cannot give their consent; breast feeding, pregnant women or women, who plan to get pregnat during the clinical trail; Patients with walking disability due to osteoarthritis III° and more; systemic neurological desease with limited mobility, e.g. Parkinson's desease or multiple sclerosis; Patients with intolerance or known limitations, that make the participation of the clinical trial impossible.

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Firma Bauerfeind AG
    • Mr.  Dr.  Uwe  Berendt 
    • Triebeser Str. 16
    • 07937  Zeulenroda–Triebes
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Klinik für Orthopädie und Unfallchirurgie, Universitätsklinikum Bonn
    • Mr.  Dr.  Yorck  Rommelspacher 
    • Sigmund Freud Str. 25
    • 53127  Bonn
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Klinik für Orthopädie und Unfallchirurgie, Universitätsklinikum Bonn
    • Mr.  Dr.  Yorck  Rommelspacher 
    • Sigmund Freud Str. 25
    • 53127  Bonn
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Firma Bauerfeind AG
    • Triebeser Straße 16
    • 07937  Zeulenroda-Triebes
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting ongoing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.